Reuters -- U.S. drugmaker Wyeth on Thursday said it tentatively settled a class-action lawsuit attempting to block its merger with Pfizer and would provide the FDA information needed to gain approval of its long-delayed osteoporosis drug.
Reuters -- U.S. drugmaker Wyeth on Thursday said it tentatively settled a class-action lawsuit attempting to block its merger with Pfizer and would provide the FDA information needed to gain approval of its long-delayed osteoporosis drug.
